Evaluation of diagnostic and therapeutic approaches for suspected influenza A(H1N1)pdm09 infection, 2009-2010

Emerging Infectious Diseases

Volumn 18, Issue 9, 2012, Pages 1414-1421

  Vijayan, Vini ^a   Jing, Jennie ^a   Zangwill, Kenneth M ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DRUG UTILIZATION; FLU LIKE SYNDROME; HUMAN; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD;

EID: 84865346274     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1809.111564     Document Type: Article

References (40)

1. World Health Organization. New influenza A (H1N1) virus: global epidemiological situation June 2009. Wkly Epidemiol Rec. 2009;84:249-257.
2. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team; Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605-2615. http://dx.doi.org/10.1056/ NEJMoa0903810
3. Centers for Disease Control and Prevention. Hospitalized patients with novel influenza A (H1N1) virus infection-California, April- May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:536-541.
4. Centers for Disease Control and Prevention. Flu activity and surveillance, 2010 -2011 [cited 2011 Jun 5]. http://www.cdc.gov/flu/weekly/.
5. Centers for Disease Control and Prevention. Interim guidance for the detection of novel influenza A virus using rapid influenza diagnostic tests [cited 2010 Dec 4]. http://www.cdc.gov/h1n1flu/guidance/rapid_testing.htm
6. Hurt AC, Baas C, Deng YM, Roberts S, Kelso A, Barr IG, et al. Performance of influenza rapid point-of-care tests in the detection of swine lineage A (H1N1) influenza viruses. Influenza Other Respi Viruses. 2009;3:171-176. http://dx.doi.org/10.1111/j.1750-2659.2009.00086.x
7. Chan KH, Lai ST, Poon LL, Guan Y, Yuen KY, Peiris JS. Analytical sensitivity of rapid influenza antigen detection tests for swine-origin influenza virus (H1N1). J Clin Virol. 2009;45:205-207.
8. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 seasons [cited 2010 Dec 4]. www.cdc.gov/h1n1/flu/ recommendations.htm#8
9. Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG, et al. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analysis of randomised control trials. BMJ. 2003;326:1235.
10. Aoki FY, MacLeod M, Paggiaro P, Carewicz O, El Sawy A, Wat C, et al. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother. 2003;51:123-129. http://dx.doi.org/10.1093/jac/dkg007
11. Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, et al. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis. 2010;50:963-969. http://dx.doi.org/10.1086/651083
12. ®: fact sheet for health care providers [cited 2010 Dec 4]. http://www.cdc.gov/h1n1flu/eua/
13. World Health Organization. Preliminary information important for understanding the evolving situation: novel influenza A (H2N1), briefing note 4, July 14, 2009 [cited 2010 Dec 21]. http://www.who.int/csr/diseae/swineflue/notes/h1n1_situation_20090724/en/index. html
14. World Health Organization. Clinical management of human infection with pandemic (H1N1) 2009: revised guidance. November 2009 [cited 2010 Nov 1]. http://www.who.int/csr/resources/publications/swineflu/clinical_management/en/index.html
15. Centers for Disease Control and Prevention. CDC issues interim recommendations for the use of influenza antiviral medications in the setting of oseltamivir resistance among circulating influenza A (H1N1) viruses, 2008-09 Influenza Season. Health Alert Network; December 19, 2008 [cited 2010 Nov 8]. http://www.bt.cdc.gov/HAN/han00279.asp
16. Centers for Disease Control and Prevention (CDC). Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009. MMWR Morbid Mortal Wkly Rep. 2009;58:969-972.
17. Dharan N, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClin-ton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA. 2009;301:1034-1041. http://dx.doi.org/10.1001/jama.2009.294
18. US Food and Drug Administration. FDA and CDC information on potential "spot shortages" of supplies for treating and preventing novel influenza A (H1N1) [cited 2010 Nov 8]. http://www.fda.gov/oc/opacom/hottopics/H1N1flu/shortages.html
19. Swerdlow DL, Finelli L, Bridges CB. 2009 H1N1 influenza pandemic: field and epidemiologic investigations in the United States at the start of the first pandemic of the 21st century. Clin Infect Dis. 2011;52(Suppl 1):S1-S3. http://dx.doi.org/10.1093/cid/ciq005
20. Khandaker G, Dierig A, Rashid H, King C, Heron L, Booy R. Systematic review of clinical and epidemiological features of the pandemic influenza A (H1N1) 2009. Influenza Other Respi Viruses. 2011;5:148-156. http://dx.doi.org/10.1111/j.1750-2659.2011.00199.x
21. ICD-9-CM Expert for Hospitals and Payers 2012, vols. 1, 2, and 3, 6th ed. Roseville (CA): Medicalcodingbooks.com Inc.; 2012.
22. Navaratnam P, Jayawant SS, Pedersen CA, Balkrishnan R. Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in the United States. Ann Allergy Asthma Immunol. 2008;100:216-221. http://dx.doi.org/10.1016/ S1081-1206(10)60445-0
23. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-1465. http:// dx.doi.org/10.1001/jama.282.15.1458
24. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpu-che-Aranda C, Hernandez M, et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med. 2009;361:674-679. http://dx.doi.org/10.1056/NEJMoa0904023
25. Qian Y-H, Su J, Shi P, He E-Q, Shao J, Sun N, et al. Attempted early detection of influenza A (H1N1) pandemic with surveillance data of influenza-like illness and unexplained pneumonia. Influenza Other Respi Viruses. 2011;5:e497-e486. http://dx.doi.org/10.1111/j.1750-2659.2011.00248.x
26. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121:258-264. http://dx.doi.org/10.1016/j. amjmed.2007.10.040
27. Centers for Disease Control and Prevention. Bacterial co-infections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMWR Morb Mortal Wkly Rep. 2009;58:1071-1074
28. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23(Suppl):S87-S97. http://dx.doi.org/10.1097/01. inf.0000108197.81270.35
29. Lee N, Cockram CS, Chan PK, Hui DS, Choi KW, Sung JJ. Antiviral treatment for patients hospitalized with severe influenza infection may affect clinical outcomes. Clin Infect Dis. 2008;46:1323-1324. http://dx.doi.org/10.1086/533477
30. McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis. 2007;45:1568-1575. http://dx.doi.org/10.1086/523584
31. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31:1166-1169. http://dx.doi.org/10.1086/317425
32. Jayawardena S, Eisdorfer J, Indulkar S, Pal SA, Sooriabalan D, Cucco R. Prescription errors and the impact of computerized prescription order entry system in a community-based hospital. Am J Ther. 2007;14:336-340. http://dx.doi.org/10.1097/01. mjt.0000209681.22077.b9
33. Wasserfallen JB, Butschi AJ, Muff P, Biollaz J, Schaller MD, Pan-natier A, et al. Format of medical order sheet improves security of antibiotics prescription: the experiences of an intensive care unit. Crit Care Med. 2004;32:655-659. http://dx.doi.org/10.1097/01. CCM.0000114835.97789.AB
34. Kaushal R, Bates DW, Landrigan C, McKenna KJ, Clapp MD, Fed-erico F, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001;285:2114-2120. http://dx.doi.org/10.1001/ jama.285.16.2114
35. Lesar TS, Lomaestro BM, Pohl H. Medication prescribing errors in a teaching hospital: a nine-year experience. Arch Intern Med. 1997;157:1569-1576. http://dx.doi.org/10.1001/ archinte.1997.00440350075007
36. Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V, et al. Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care. 2003;15:331-335. http://dx.doi. org/10.1093/intqhc/mzg046
37. Cantú TG, Ellerbeck EF, Yun SW, Castine SD, Kornhauser DM. Drug prescribing for patients with changing renal function. Am J Hosp Pharm. 1992;49:2944-2948.
38. Raisch DW, Straight TM, Holodniy M. Thrombocytopenia from combination treatment with oseltamivir and probenicid: case report, MedWatch data summary, and review of the literature. Pharmaco-therapy. 2009;29:988-992. http://dx.doi.org/10.1592/phco.29.8.988
39. Centers for Disease Control and Prevention. Neurologic complications associated with novel influenza A (H1N1) virus infection in children-Dallas, Texas, May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:773-778.
40. Fleming DM, Pannell RS, Elliot AJ, Cross KW. Respiratory illness associated with influenza and respiratory syncytial virus infection. Arch Dis Child. 2005;90:741-746. http://dx.doi.org/10.1136/ adc.2004.063461